Summary
C57Bl and CBA mice of different ages (6, 12, 26 or 35 weeks) received intramuscular inocula of melanoma B16 or mammary adenocarcinoma (MCa), respectively. Median survival time was shorter, the younger the recipients. Tumor enlargement was correspondingly retarded in older mice. This was associated with decrease of natural killer (NK) activity in the spleens. However, the cytotoxicity against fresh syngeneic tumor cells, increased with age in CBA mice. In contrast to the growth of intramuscular tumors, the ability of intravenously injected B16 or MCa cells to form nodules in the lungs was significantly superior in old animals (35 weeks or more), with low levels of NK activity, than in young ones (6 weeks) with high levels of NK activity. Stimulation of NK activity by poly(I) · poly(C) reduced the number of MCa colonies by 50% in the lungs of old mice, but had no effect on colony-forming ability in young animals. The observed association of tumor growth with age and NK activity levels may reflect (a) an interplay of tumor-inhibiting and tumor-promoting effects of NK cells, changing with age, and (b) the accessibility of tumor cells, inoculated intramuscularly or captured in the lungs, to these influences.
Similar content being viewed by others
References
Albright JW, Albright J (1983) Age-associated impairment of murine natural killer activity. Proc Natl Acad Sci USA 80: 6371
Almawi WY, Pope BL (1987) Enhancement of tumor growth by suppressor factors derived from a natural suppressor/cytotoxic cell line. Transplantation 45: 998
Ames IH, Gates CE, Garcia AM, John PA, Henning AK, Tomar RH (1987) Lysis of fresh murine mammary tumor cells by syngeneic natural killer cells and lymphokine-activated killer cells. Cancer Immunol Immunother 25: 161
Azuma E, Kaplan J (1988) Role of lymphokine-activated killer cells as mediators of veto and natural suppression. J Immunol 141: 2601
Djeu JY, Heinbaugh JA, Holden HT, Herberman RB (1979) Augmentation of mouse natural killer cell activity by interferon and interferon inducers. J Immunol 122: 175
Ershler WB, Moore AL, Shore H, Gamelli RL (1984a) Transfer of age-associated restrained tumor growth in mice by old-to-young bone marrow transplantation. Cancer Res 44: 5677
Ershler WB, Stewart JA, Hacker MP, Moore AX, Tindle BH (1984b) B16 murine melanoma and aging: slower growth and longer survival in old mice. JNCI 72: 161
Ershler WB, Bertram E, Moore AL (1986) Slower melanoma B16 growth but greater pulmonary colonization in calorie-restricted mice. JNCI 76: 81
Fidler IJ (1974) Immune stimulation-inhibition of experimental cancer metastasis. Cancer Res 34: 491
Gabrilovac J, Tomašić J, Boranić M, Martin-Kleiner I, Osmak M (1989) In vivo and in vitro modulation of NK and ADCC activity of mouse spleen cells by peptidoglycan monomer (PGM). Res Exp Med 189: 265
Hanna N, Fidler IJ (1980) Role of natural killer cells in the destruction of circulating tumor emboli. JNCI 66: 801
Herberman RB, Ortaldo JR (1981) Natural killer cells: their role in the defense against disease. Science 214: 24
Kaminski M, Auerbach R (1988) Tumor cells are protected from NK-cell-mediated lysis by adhesion to endothelial cells. Int J Cancer 41: 847
Kreisle RA, Stebler BA, Ershler WB (1990) Effect of host age on tumor associated angiogenesis in mice. JNCI 82: 44
Lanza E, Djeu JY (1982) Age-independent natural killer cell activity in murine blood. In: Herberman RB (ed) NK cells and other natural effector cells. Academic Press, New York, p 335
More R, Yron I, Sasson SB, Weiss DW (1975) In vitro studies on cell-mediated cytotoxicity by means of terminal labeling technique. Cell Immunol 15: 382
Pawelec G, Wernet P, Newman W (1986) Recognitive heterogeneity of NK cells. In: Herberman RB, Callewaert DM (eds) Mechanism of cytotoxicity by NK cells. Academic Press, Orlando, London, p 655
Poljak-Blaži M, Boranić M, Maržan B, Radačić M (1981) A transplantable aplastic mammary carcinoma of CBA mice. Vet Arh 51: 99
Prehn RT (1972) The immune reaction as a stimulator of tumor growth. Science 176: 170
Proctor JW, Auclair BG, Stokowski L (1976) Brief communication: endocrine factors and the growth and spread of B16 melanoma. JNCI 57: 1197
Simon SR, Ershler WB (1985) Hormonal influence on the growth of B16 melanoma. JNCI 74: 1084
Tsuda T, Kim YT, Siskind GW, De Blasio A, Schwab R, Ershler W, Weksler ME (1987) Role of the thymus and T cells in slow growth of B16 melanoma in old mice. Cancer Res 47: 3097
Yuhas JM, Pazmino NH, Proctor JO, Toya RE (1974) A direct relationship between immune competence and the subcutaneous growth rate of malignant murine lung tumor. Cancer Res 34: 722
Zoller M, Strubel A, Hammerling G, Andrighetto G, Raz A, Ben-Ze'Ev A (1988) Interferon-gamma treatment of B16 melanoma cells: opposing effects for non-adaptive and adaptive immune defense and its reflection by metastatic spread. Int J Cancer 41: 256
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gabrilovac, J., Radačić, M., Osmak, M. et al. Opposing influence of age on the growth and colony-forming ability of mouse melanoma B16 and mammary adenocarcinoma: Correlation with natural killer activity. Cancer Immunol Immunother 32, 45–50 (1990). https://doi.org/10.1007/BF01741723
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01741723